Imbed Biosciences Inc (Imbed) operates as a medical device company that develops technologies for imbedding bioactive molecules in wound dressings and surgical implants. The company’s polymeric microfilm product platform develops bioactive molecules on tissue surfaces to manage wound infections, biofilms and local pain and support wound healings. It conducts research for the development of antibacterial, antibiofilm and analgesic wound dressings. Imbed’s antibiofilm wound dressing is an ultra-thin transparent film wound dressings made with polymeric films containing silver nanoparticles. The company’s analgesic wound dressing contains minuscule loadings of topical NSAID analgesics to relieve local pain in dermal wounds. Imbed is headquartered in Madison, Wisconsin, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Imbed Biosciences Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Imbed Biosciences Inc Company Overview
- Imbed Biosciences Inc Company Snapshot
- Imbed Biosciences Inc Pipeline Products and Ongoing Clinical Trials Overview
- Imbed Biosciences Inc - Pipeline Analysis Overview
- Imbed Biosciences Inc - Key Facts
- Imbed Biosciences Inc - Major Products and Services
- Imbed Biosciences Inc Pipeline Products by Development Stage
- Imbed Biosciences Inc Ongoing Clinical Trials by Trial Status
- Imbed Biosciences Inc Pipeline Products Overview
- Antibiofilm Next-Generation Microlyte Matrix
- Antibiofilm Next-Generation Microlyte Matrix Product Overview
- Antimicrobial Matrix - Wound and Pain Management
- Antimicrobial Matrix - Wound and Pain Management Product Overview
- Antimicrobial Temporizing Burn Matrix
- Antimicrobial Temporizing Burn Matrix Product Overview
- MicroLyte Ag-Ga Wound Matrix
- MicroLyte Ag-Ga Wound Matrix Product Overview
- MicroLyte Ag-Ga Wound Matrix Clinical Trial
- Microlyte PLUS
- Microlyte PLUS Product Overview
- Nasal Spray
- Nasal Spray Product Overview
- PelashieldAM
- PelashieldAM Product Overview
- Imbed Biosciences Inc - Key Competitors
- Imbed Biosciences Inc - Key Employees
- Imbed Biosciences Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Imbed Biosciences Inc, Recent Developments
- Mar 11, 2025: Imbed Biosciences Announces FDA IDE Approval for Silver-Gallium Synthetic Antimicrobial Matrix Clinical Study With Human Donor Site Wounds
- Oct 31, 2024: Imbed Biosciences Receives FDA 510(k) Clearance for Microlyte Ag/Lidocaine
- Oct 25, 2024: Imbed Biosciences Receives 510(K) Clearance For Microlyte Ag
- Feb 01, 2024: Imbed Biosciences Awarded Skin Integrity and Wound Care Agreement with Premier
- Oct 05, 2023: Spartan Medical Launches Concentric Attack on Surgical Site Infections
- Feb 15, 2022: Imbed’s Microlyte Matrix added to VA’s IDIQ contract
- Nov 10, 2021: Imbed Biosciences wins a $2M award from the U.S. Army to prevent combat wound infections
- Oct 14, 2021: NIH awards Imbed Biosciences $800K SBIR grant to kill bacteria in biofilms
- Oct 12, 2021: Microlyte SURGICAL associated with positive outcomes in prospective clinical case series in patients at risk for surgical site infection
- Aug 24, 2021: Imbed Biosciences partners with Spartan Medical to provide advanced surgical and wound care products to U.S. Veterans and Military Members
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Imbed Biosciences Inc Pipeline Products and Ongoing Clinical Trials Overview
- Imbed Biosciences Inc Pipeline Products by Equipment Type
- Imbed Biosciences Inc Pipeline Products by Indication
- Imbed Biosciences Inc Ongoing Clinical Trials by Trial Status
- Imbed Biosciences Inc, Key Facts
- Imbed Biosciences Inc, Major Products and Services
- Imbed Biosciences Inc Number of Pipeline Products by Development Stage
- Imbed Biosciences Inc Pipeline Products Summary by Development Stage
- Imbed Biosciences Inc Ongoing Clinical Trials by Trial Status
- Imbed Biosciences Inc Ongoing Clinical Trials Summary
- Antibiofilm Next-Generation Microlyte Matrix - Product Status
- Antibiofilm Next-Generation Microlyte Matrix - Product Description
- Antimicrobial Matrix - Wound and Pain Management - Product Status
- Antimicrobial Matrix - Wound and Pain Management - Product Description
- Antimicrobial Temporizing Burn Matrix - Product Status
- Antimicrobial Temporizing Burn Matrix - Product Description
- MicroLyte Ag-Ga Wound Matrix - Product Status
- MicroLyte Ag-Ga Wound Matrix - Product Description
- MicroLyte Ag-Ga Wound Matrix - Feasibility Clinical Trial to Validate the Safety of Polymeric Matrix with Silver and Gallium Ions
- Microlyte PLUS - Product Status
- Microlyte PLUS - Product Description
- Nasal Spray - Product Status
- Nasal Spray - Product Description
- PelashieldAM - Product Status
- PelashieldAM - Product Description
- Imbed Biosciences Inc, Key Employees
- Glossary
- Imbed Biosciences Inc Pipeline Products by Equipment Type
- Imbed Biosciences Inc Pipeline Products by Development Stage
- Imbed Biosciences Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Hollister Inc
- Medline Industries LP
- 3M Health Care
